secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dermata Therapeutics, Inc. (DRMA)
CIK:        0001853816
Form:       8-K
Filed at:   2026-01-27T23:59:59+00:00
Accession:  0001493152-26-003715
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dermata increases ATM offering capacity by $705K; previously sold $3.45M under same program
--------------------------------------------------------------------------------

- Filed prospectus supplement to increase maximum aggregate offering under ATM by $705,000.
- Prior sales under the June 2024 H.C. Wainwright ATM agreement totaled $3,454,390.
- ATM program covers common stock issuances; legal opinion filed as Exhibit 5.1.
- No change in business fundamentals; routine capital access expansion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1853816/000149315226003715/0001493152-26-003715-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1853816/000149315226003715/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-003715

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer